NEWSROOM

ALL Press Release Awards Media Center

Press Release

2024. 06. 05

Innorna receives IND clearance for its first-in-class bivalent RSV mRNA vaccine in China

Press Release

2024. 04. 17

Innorna's broad-spectrum SARS-CoV-2 mRNA vaccine receives Phase II clinical trial approval from FDA

Press Release

2024. 01. 12

Innorna Receives IND Clearance by FDA Enabling Phase I Initiation for Bivalent Respiratory Syncytial Virus mRNA Vaccine

Press Release

2023. 09. 23

Innorna Receives IND Clearance by FDA Enabling Phase I Initiation for Herpes Zoster mRNA Vaccine

Press Release

2022. 07. 07

Innorna and BeiGene Launch Strategic Collaboration to Develop Innovative mRNA Products

Press Release

2023. 02. 25

Innorna’s SARS-CoV-2 mRNA vaccine received FDA clearance for Phase I clincial trial

Press Release

2023. 02. 25

Innorna’s SARS-CoV-2 mRNA vaccine received FDA clearance for Phase I clincial trial

Press Release

2022. 12. 20

Innorna’s Covid mRNA Vaccine Approved by New Zealand for Phase I Clinical Trial

Press Release

2022. 07. 06

Innorna and BeiGene Announce Strategic Research Collaboration to Jointly Discover Novel mRNA Therapies

Press Release

2022. 03. 28

Innorna raises USD 120 million in Series B funding

Press Release

2021. 07. 28

Innorna raises hundreds of millions RMB in Series A funding